22h
Zacks Investment Research on MSNBiotech Stock Roundup: CORT Up on Study Data, Updates From AXSM, BMY, EXEL & MoreIt was a busy week in the biotech sector, marked by significant regulatory and pipeline updates. Among these, shares of ...
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...
Mirvetuximab soravtansine improved overall survival, progression-free survival, second progression-free survival, and other outcomes.
10h
News-Medical.Net on MSNMouse and organoid models reveal FGFR2's role in pancreatic cancer aggression and interceptionPancreatic cancer is projected to become the second-deadliest cancer by 2030. By the time it's diagnosed, it's often ...
Laura Bobolts, PharmD, BCOP, senior vice president of clinical strategy and growth at OncoHealth, discusses strategies for managing costs of novel cellular and gene therapies in the oncology pipeline.
When taken as directed, norgestrel has 98% efficacy in preventing pregnancy in individuals who are adherent to the daily regimen.
Real time quote data is not available at this time. *Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change. **Green ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results